Financial Snapshot

Revenue
$790.4M
TTM
Gross Margin
93.52%
TTM
Net Earnings
-$16.22M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
548.09%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$696.4M
Q3 2024
Cash
Q3 2024
P/E
-119.1
Nov 29, 2024 EST
Free Cash Flow
$108.6M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $750.3M $766.6M $745.4M $550.7M $388.2M $249.5M $157.2M $99.40M
YoY Change -2.12% 2.83% 35.36% 41.85% 55.59% 58.73% 58.15%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $750.3M $766.6M $745.4M $550.7M $388.2M $249.5M $157.2M $99.40M
Cost Of Revenue $66.93M $65.08M $46.72M $29.60M $14.00M $6.000M $3.100M $1.200M
Gross Profit $683.3M $701.5M $698.7M $521.1M $374.2M $243.5M $154.2M $98.10M
Gross Profit Margin 91.08% 91.51% 93.73% 94.63% 96.39% 97.59% 98.09% 98.69%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Selling, General & Admin $466.8M $502.4M $524.9M $716.6M $191.7M $112.5M $83.30M $64.50M
YoY Change -7.08% -4.28% -26.75% 273.89% 70.31% 35.1% 29.15%
% of Gross Profit 68.32% 71.62% 75.12% 137.51% 51.22% 46.22% 54.02% 65.75%
Research & Development $135.8M $143.1M $125.9M $61.82M $29.30M $43.89M $11.50M $5.700M
YoY Change -5.1% 13.73% 103.6% 110.98% -33.25% 281.69% 101.75%
% of Gross Profit 19.88% 20.41% 18.01% 11.86% 7.83% 18.03% 7.46% 5.81%
Depreciation & Amortization $4.800M $4.600M $4.000M $1.400M $700.0K $300.0K $9.100M $9.100M
YoY Change 4.35% 15.0% 185.71% 100.0% 133.33% -96.7% 0.0%
% of Gross Profit 0.7% 0.66% 0.57% 0.27% 0.19% 0.12% 5.9% 9.28%
Operating Expenses $602.7M $645.6M $650.8M $778.4M $221.0M $156.4M $103.8M $79.40M
YoY Change -6.64% -0.8% -16.4% 252.28% 41.25% 50.7% 30.73%
Operating Profit -$27.01M $1.738M $13.41M -$275.7M $139.7M $77.25M $50.40M $18.70M
YoY Change -1653.91% -87.04% -104.86% -297.4% 80.81% 53.28% 169.52%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Interest Expense -$24.56M -$24.97M -$23.58M -$27.80M -$48.90M -$22.00M -$6.900M -$3.500M
YoY Change -1.65% 5.88% -15.17% -43.15% 122.27% 218.84% 97.14%
% of Operating Profit -1436.65% -175.91% -35.01% -28.48% -13.69% -18.72%
Other Income/Expense, Net -$28.57M -$24.97M -$23.58M -$27.73M -$56.70M -$24.90M $0.00 -$200.0K
YoY Change 14.4% 5.88% -14.96% -51.09% 127.68% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Pretax Income -$55.57M -$23.23M -$10.18M -$303.5M $82.98M $52.35M $39.70M $15.10M
YoY Change 139.21% 128.27% -96.65% -465.7% 58.51% 31.86% 162.91%
Income Tax -$46.70M $9.597M $15.08M -$9.827M $16.93M $8.555M $10.90M $6.200M
% Of Pretax Income 20.4% 16.34% 27.46% 41.06%
Net Earnings -$8.868M -$32.83M -$25.25M -$293.6M $66.05M $43.79M $28.80M $8.900M
YoY Change -72.99% 29.99% -91.4% -544.56% 50.82% 52.06% 223.6%
Net Earnings / Revenue -1.18% -4.28% -3.39% -53.32% 17.01% 17.55% 18.32% 8.95%
Basic Earnings Per Share -$0.02 -$0.08 -$0.06 -$1.07 $0.19 $0.12
Diluted Earnings Per Share -$0.02 -$0.08 -$0.06 -$1.07 $0.18 $0.12 $75.16K $23.23K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Cash & Short-Term Investments $672.3M $757.2M $941.1M $968.7M $26.10M $34.60M
YoY Change -11.21% -19.55% -2.85% 3611.49% -24.57%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $53.35M $40.86M $21.31M $20.40M $12.40M $3.400M
YoY Change 30.58% 91.75% 4.45% 64.52% 264.71%
Inventory
Prepaid Expenses
Receivables $143.6M $117.1M $118.1M $68.70M $48.10M $33.40M
Other Receivables $3.537M $4.524M $8.331M $28.60M $0.00 $1.600M
Total Short-Term Assets $872.8M $919.7M $1.089B $1.086B $86.60M $73.10M
YoY Change -5.1% -15.53% 0.22% 1154.5% 18.47%
Property, Plant & Equipment $45.86M $55.73M $49.32M $50.80M $34.20M $1.000M
YoY Change -17.7% 13.0% -2.92% 48.54% 3320.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $103.0M $27.17M $6.007M $15.10M $3.400M $2.000M
YoY Change 279.32% 352.22% -60.22% 344.12% 70.0%
Total Long-Term Assets $716.0M $684.9M $518.8M $383.7M $300.2M $241.7M
YoY Change 4.54% 32.03% 35.21% 27.81% 24.2%
Total Assets $1.589B $1.605B $1.608B $1.470B $386.8M $314.8M
YoY Change
Accounts Payable $36.27M $17.70M $17.50M $10.30M $7.900M $7.200M
YoY Change 104.89% 1.14% 69.91% 30.38% 9.72%
Accrued Expenses $70.40M $43.71M $49.71M $35.40M $13.70M $3.700M
YoY Change 61.06% -12.07% 40.44% 158.39% 270.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $8.787M $7.029M $7.029M $7.000M $7.000M $5.400M
YoY Change 25.01% 0.0% 0.41% 0.0% 29.63%
Total Short-Term Liabilities $122.6M $76.32M $81.11M $59.60M $33.40M $16.60M
YoY Change 60.59% -5.91% 36.1% 78.44% 101.2%
Long-Term Debt $647.7M $651.8M $655.9M $659.9M $663.9M $716.8M
YoY Change -0.63% -0.62% -0.61% -0.6% -7.38%
Other Long-Term Liabilities $56.58M $61.69M $38.73M $39.30M $40.10M $3.300M
YoY Change -8.28% 59.28% -1.45% -2.0% 1115.15%
Total Long-Term Liabilities $704.3M $713.5M $694.6M $699.2M $704.0M $720.1M
YoY Change -1.29% 2.72% -0.66% -0.68% -2.24%
Total Liabilities $826.8M $789.8M $775.9M $758.8M $737.4M $740.2M
YoY Change 4.69% 1.79% 2.26% 2.9% -0.38%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Basic Shares Outstanding 410.3M shares 412.9M 410.0M 274.7M 226.6M 111.8M
Diluted Shares Outstanding 410.3M shares 412.9M 410.0M 274.7M 231.2M 118.3M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.9324 Billion

About GoodRx Holdings, Inc.

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 694 full-time employees. The company went IPO on 2020-09-23. The company offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. The company also equips healthcare professionals to find and prescribe affordable medications. The company offers information and tools to help consumers compare prices and save on their prescription drug purchases. The company operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). The company also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.

Industry: Services-Computer Processing & Data Preparation Peers: Veradigm Inc. MultiPlan Corp Certara, Inc. Definitive Healthcare Corp. Evolent Health, Inc. Phreesia, Inc. Schrodinger, Inc.